Novan logo
Novan NOVN
report update icon

Quarterly report 2023-Q1
added 05-16-2026

Novan Market Cap | NOVN

As of November 22, 2026 Novan has a market cap of $ 2.64 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Novan

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
26.2 M 62.3 M 140 M 57.8 M 320 M 503 M 902 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
902 M 26.2 M 288 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Kiniksa Pharmaceuticals, Ltd. Kiniksa Pharmaceuticals, Ltd.
KNSA
3.28 B $ 93.83 0.32 % $ 6.96 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
1.63 B $ 27.54 -4.24 % $ 1.6 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
18.9 B $ 68.45 1.08 % $ 29.4 B usaUSA
Equillium Equillium
EQ
118 M $ 1.06 -5.36 % $ 60.7 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
125 M $ 1.32 -5.04 % $ 75.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
252 M $ 2.42 -1.17 % $ 128 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.65 B $ 17.1 -2.79 % $ 2.88 B usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
46.7 M $ 1.6 -8.86 % $ 13.8 M usaUSA
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
56.9 M - -7.31 % $ 49 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
6.34 B $ 112.31 -3.84 % $ 7.3 B usaUSA
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
616 M - - $ 1.77 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
139 M $ 1.29 -2.28 % $ 164 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
1.61 B $ 32.58 -1.21 % $ 1.87 B usaUSA
Ardelyx Ardelyx
ARDX
1.62 B $ 2.99 -2.25 % $ 721 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
334 M $ 0.39 -8.41 % $ 100 M usaUSA
Alector Alector
ALEC
247 M $ 2.34 1.52 % $ 241 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
114 M $ 1.06 3.43 % $ 56.9 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
4.31 B $ 21.12 -1.26 % $ 6.62 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
847 M $ 4.03 -1.11 % $ 772 M canadaCanada
Agenus Agenus
AGEN
97.8 M $ 5.97 -2.85 % $ 178 M usaUSA
PolyPid Ltd. PolyPid Ltd.
PYPD
67.7 M $ 6.1 -6.87 % $ 99.7 M israelIsrael
AbCellera Biologics AbCellera Biologics
ABCL
962 M $ 9.63 -8.02 % $ 2.88 B canadaCanada
Artelo Biosciences Artelo Biosciences
ARTL
255 K $ 1.35 -6.9 % $ 255 K usaUSA
Immatics N.V. Immatics N.V.
IMTX
735 M $ 5.76 -3.19 % $ 705 M germanyGermany
Aptevo Therapeutics Aptevo Therapeutics
APVO
1.42 M $ 0.4 -2.61 % $ 126 K usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
65.9 M $ 1.22 -2.4 % $ 12.1 M usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
385 M $ 3.44 -1.86 % $ 422 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
2.48 B $ 27.46 -2.1 % $ 4.17 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
7.49 M $ 0.83 -8.27 % $ 2.16 M usaUSA
Biofrontera AG Biofrontera AG
BFRA
220 M - -8.24 % $ 105 M germanyGermany
SIGA Technologies SIGA Technologies
SIGA
404 M $ 2.4 -9.06 % $ 172 M usaUSA
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
80.6 M - -6.97 % $ 657 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
1.45 B $ 7.56 0.4 % $ 351 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.25 B $ 28.3 0.68 % $ 1.32 B usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
4.56 B - 1.68 % $ 4.65 B chinaChina
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
203 M $ 55.64 2.88 % $ 155 M israelIsrael
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
1.73 B $ 8.71 -4.16 % $ 755 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
467 M $ 3.47 -6.48 % $ 371 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
81.6 M $ 0.59 -4.42 % $ 36.2 M usaUSA
Jaguar Health Jaguar Health
JAGX
956 K $ 0.24 -27.06 % $ 560 K usaUSA
Arvinas Arvinas
ARVN
869 M $ 6.41 -4.9 % $ 454 M usaUSA
Cerus Corporation Cerus Corporation
CERS
496 M $ 1.86 -2.37 % $ 355 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
3.2 B $ 20.87 -0.36 % $ 2.06 B usaUSA
Inhibrx Inhibrx
INBX
1.75 B $ 68.81 -7.43 % $ 3.24 B usaUSA
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
5.09 B $ 48.09 -4.54 % $ 5.52 B usaUSA
Revolution Medicines Revolution Medicines
RVMD
19.6 B $ 161.01 0.99 % $ 30.6 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
89.6 M $ 3.29 0.15 % $ 152 M israelIsrael
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
521 M - - $ 459 M usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
6.91 B $ 15.21 -5.53 % $ 5.61 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
931 M $ 2.04 -0.73 % $ 281 M usaUSA